Lhermitte-Duclos disease is a clinical manifestation of Cowden's syndrome

N Vantomme1, F Van Calenbergh, J Goffin

  • 1Department of Neurosurgery, University Hospital Gasthuisberg, Leuven, Belgium.

Surgical Neurology
|October 13, 2001
PubMed

Insights

Lhermitte-Duclos disease (LDD) is often linked to Cowden

Area of Science:

  • Neurology
  • Genetics
  • Oncology

Background:

  • Lhermitte-Duclos disease (LDD) involves hamartomatous overgrowth of cerebellar cells.
  • Cowden's syndrome (CS) is an autosomal dominant disorder with multiple hamartomas and neoplastic lesions.
  • Increasing reports suggest an association between LDD and CS.

Purpose of the Study:

  • To investigate the association between LDD and Cowden's syndrome.
  • To identify clinical findings suggestive of CS in patients with LDD.

Main Methods:

  • Retrospective review of medical records and imaging studies.
  • Analysis of six patients diagnosed with LDD.
  • Screening for additional symptoms indicative of CS.

Main Results:

  • Five out of six LDD patients exhibited mucocutaneous lesions, acral keratosis, thyroid adenoma, fibrocystic disease, ovarian cysts, intestinal polyposis, or arteriovenous malformation.
  • The youngest patient (5-year-old boy) showed no cutaneous or other signs of CS.
  • Clinical findings strongly suggest a link between LDD and CS.

Conclusions:

  • LDD may represent a neurological manifestation of Cowden's syndrome.
  • Comprehensive dermatological and systemic screening is crucial for LDD patients.
  • Early detection of CS-related lesions can prevent malignant transformation.
Abstract

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...